News articles published regarding our UCon project
The Innovation Fund Denmark and Avisen Danmark have both published an article regarding our project UCon. Additionally, 14 regional/local newspapers in Denmark have picked up the story. The articles describe the problem regarding incontinence. Many suffer in silence, and studies show that every fifth adult in Denmark can experience it. In many cases, people suffering experience low quality of life. However, our new device UCon has been approved for clinical trials and will hopefully benefit a large group of patients. UCon is expected to be CE marked early 2024. Four Danish doctors, Peter Christensen, and Jakob Duelund-Jakobsen from Aarhus Universitetshospital, Niels Klarskov from Herlev Hospital, and Niels Qvist from Odense Universitetshospital are involved in the development of UCon, and 40 selected patients from all over Denmark will test UCon for a month. The Innovation Fund Denmark is supporting the project with 6.5 million DKK. Peter Christensen, professor & colorectal surgeon from Aarhus Universitetshospital, has been interviewed for the articles and states the following: "If UCon works, it means that some patients will find a working solution, instead of suffering many uncontrolled toilet visits a day together with frequent incontinence episodes." Christensen also highlights that current neurostimulation treatments are expensive & invasive, and UCon has the potential to fill a gap in the field of incontinence treatments: "UCon accesses the relevant nerves and offers an easily accessible and affordable solution that does not require surgery.". He continues: "With the new UCon product from InnoCon Medical, it will probably be possible for us to lower the indications for offering neurostimulation as treatment, and thereby help more patients." We, together with our clinical partners, look forward to the results of the clinical trials and hope UCon can offer a desirable treatment option for many patients in need. Enrollment for the clinical study is going well, here in June we are halfway as planned.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.